Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Beeson

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Current Opinion in Neurology|July 30, 2016
Congenital myasthenic syndromes: recent advancesDavid Beeson
Muscle & Nerve|July 1, 2026
The Differing Phenotypes of the Three Most Common Postsynaptic Congenital Myasthenic Syndromes Governed by Their Underlying Molecular Pathogenic MechanismsDavid Beeson
Annals of the New York Academy of Sciences|January 3, 2013
Synaptic dysfunction in congenital myasthenic syndromesDavid Beeson
Handbook of Clinical Neurology|August 22, 2024
Congenital myasthenic syndromesDavid Beeson
Journal of Neuroimmunology|August 19, 2008
The congenital myasthenic syndromesJackie Palace, David Beeson
Neuromuscular Disorders : NMD|November 5, 2021
Congenital myasthenic syndromes: where do we go from here?Sithara Ramdas, David Beeson
Current Opinion in Neurology|July 31, 2019
The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategiesAn E Vanhaesebrouck, David Beeson
The Journal of Gene Medicine|June 22, 2007
Hairpin DNAzymes: a new tool for efficient cellular gene silencingAmr Abdelgany, Matthew Wood, David Beeson
Journal of Neuromuscular Diseases|June 6, 2018
Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic DisordersLisa Clausen, Judith Cossins, David Beeson
Human Molecular Genetics|August 21, 2003
Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interferenceAmr Abdelgany, Matthew Wood, David Beeson
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Current Opinion in Neurology|July 30, 2016
Congenital myasthenic syndromes: recent advancesDavid Beeson
Muscle & Nerve|July 1, 2026
The Differing Phenotypes of the Three Most Common Postsynaptic Congenital Myasthenic Syndromes Governed by Their Underlying Molecular Pathogenic MechanismsDavid Beeson
Annals of the New York Academy of Sciences|January 3, 2013
Synaptic dysfunction in congenital myasthenic syndromesDavid Beeson
Handbook of Clinical Neurology|August 22, 2024
Congenital myasthenic syndromesDavid Beeson
Journal of Neuroimmunology|August 19, 2008
The congenital myasthenic syndromesJackie Palace, David Beeson
Neuromuscular Disorders : NMD|November 5, 2021
Congenital myasthenic syndromes: where do we go from here?Sithara Ramdas, David Beeson
Current Opinion in Neurology|July 31, 2019
The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategiesAn E Vanhaesebrouck, David Beeson
The Journal of Gene Medicine|June 22, 2007
Hairpin DNAzymes: a new tool for efficient cellular gene silencingAmr Abdelgany, Matthew Wood, David Beeson
Journal of Neuromuscular Diseases|June 6, 2018
Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic DisordersLisa Clausen, Judith Cossins, David Beeson
Human Molecular Genetics|August 21, 2003
Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interferenceAmr Abdelgany, Matthew Wood, David Beeson
Pageof 14